In particular, ShcA upregulates the levels of PGC-1α, which regulates mitochondrial metabolism and allows breast cancer cells to efficiently metabolise both glucose and glutamine and satisfy cancer bioenergetic and biosynthetic requests [144]. Here, PPARGC1A is linked to breast cancer.